Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-02-09

Clinical Trial Update: Clinical Evaluation of BD NEXT Pen Needle

View source ↗

Summary

This clinical trial update indicates the BD NEXT Pen Needle clinical evaluation has completed in participants with type 1 and type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BD NEXT Pen Needle

Snippet

Sponsor: Becton, Dickinson and Company | Conditions: Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 1 | Status: COMPLETED